COVID-19疫情对中国抗血管内皮生长因子治疗的影响：表1

数据集获取（Figshare）

• 源站标题：Table_1_Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China.DOCX
• DOI：10.3389/fmed.2020.576275.s001
• 发布日期：2020-12-14
• 文件数：1 个
• 文件总体积：16.78 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_1_Effects_of_the_COVID-19_Pandemic_on_Anti-vascular_Endothelial_Growth_Factor_Treatment_in_China_DOCX/13372127

命令行下载

curl -L -o "Table_1_Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China.DOCX" "https://ndownloader.figshare.com/files/25766252"

文件清单

• Table_1_Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China.DOCX（16.78 KB）

文件总体积 16.78 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

We evaluated the impact of the COVID-19 pandemic on anti-VEGF treatment in ophthalmology patients in a single hospital in northern China. A total of 93 anti-VEGF injections were administered to 85 eyes of 72 patients at The China Medical University First Hospital Department of Ophthalmology during the COVID-19 pandemic. Compared to the same period in 2019, the number of injections decreased by 70%. Fifty-nine eyes of 46 patients were receiving 3+PRN anti-VEGF treatment prior to the outbreak of the COVID-19 pandemic; all of these patients experienced treatment interruptions due to COVID-19-associated reasons. Anatomic and functional outcomes suggest that patients with anti-VEGF treatment interruptions are at risk for severe adverse visual sequelae. Moreover, deferred anti-VEGF treatment due to patient-related or department-related reasons during the COVID-19 pandemic may result in poor visual outcomes for new patients. Our results suggest that COVID-19 has had a significant negative effect on anti-VEGF treatment in ophthalmology patients. Detailed guidance from global experts in ophthalmology is highly sought after in these challenging circumstances.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fmed.2020.576275.s001（source: https://frontiersin.figshare.com/articles/dataset/Table_1_Effects_of_the_COVID-19_Pandemic_on_Anti-vascular_Endothelial_Growth_Factor_Treatment_in_China_DOCX/13372127）。